Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA

European Journal of Immunology

Volumn 43, Issue 10, 2013, Pages 2683-2695

  Palomo, Jennifer ^a,b   Fauconnier, Mathilde ^a,b   Coquard, Laurie ^a,b   Gilles, Maïlys ^a,b   Meme, Sandra ^c   Szeremeta, Frederic ^c   Fick, Lizette ^d   Franetich, Jean François ^e,f,g   Jacobs, Muazzam ^d   Togbe, Dieudonnée ^h   Beloeil, Jean Claude ^c   Mazier, Dominique ^e,f,g   Ryffel, Bernhard ^a,b,d   Quesniaux, Valerie F J ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^d Institute of Infectious Disease and Molecular Medicine   (South Africa)

^e SORBONNE UNIVERSITÉ   (France)

^f INSERM   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h Centre d'Innovation   (France)

Author keywords

Chemokines; Experimental cerebral malaria; Merozoites; Sporozoites; Type I interferons (IFNs)

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR 1; GRANZYME B; INTERFERON; INTERLEUKIN 12 RECEPTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CIRCULATION; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROZOITE; T LYMPHOCYTE ACTIVATION;

CHEMOKINES; EXPERIMENTAL CEREBRAL MALARIA; MEROZOITES; SPOROZOITES; TYPE I INTERFERONS (IFNS);

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CEREBELLUM; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; HUMANS; INTERFERON TYPE I; ISCHEMIA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; MODELS, ANIMAL; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; RECEPTORS, CXCR3; RECEPTORS, INTERFERON; SPOROZOITES;

EID: 84885735527     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343327     Document Type: Article

References (51)

1. Idro, R., Jenkins, N. E. and Newton, C. R., Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005. 4: 827-840.
2. Hunt, N. H. and Grau, G. E., Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003. 24: 491-499.
3. Craig, A. G., Grau, G. E., Janse, C., Kazura, J. W., Milner, D., Barnwell, J. W., Turner, G. et al., The role of animal models for research on severe malaria. PLoS Pathog. 2012. 8: e1002401.
4. Renia, L., Potter, S. M., Mauduit, M., Rosa, D. S., Kayibanda, M., Deschemin, J. C., Snounou, G. et al., Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 2006. 36: 547-554.
5. Schofield, L. and Grau, G. E., Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 2005. 5: 722-735.
6. Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J. C., van Rooijen, N., Viguier, M., Snounou, G. et al., On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 2002. 169: 6369-6375.
7. Nitcheu, J., Bonduelle, O., Combadiere, C., Tefit, M., Seilhean, D., Mazier, D. and Combadiere, B., Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 2003. 170: 2221-2228.
8. Fauconnier, M., Bourigault, M. L., Meme, S., Szeremeta, F., Palomo, J., Danneels, A., Charron, S. et al., Protein kinase C-theta is required for development of experimental cerebral malaria. Am. J. Pathol. 2011. 178: 212-221.
9. Srivastava, K. K., Batra, S., Sassano, A., Li, Y., Majchrzak, B., Kiyokawa, H., Altman, A. et al., Engagement of protein kinase C-theta in interferon signaling in T-cells. J. Biol. Chem. 2004. 279: 29911-29920.
10. Grau, G. E., Heremans, H., Piguet, P. F., Pointaire, P., Lambert, P. H., Billiau, A. and Vassalli, P., Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1989. 86: 5572-5574.
11. Amani, V., Vigario, A. M., Belnoue, E., Marussig, M., Fonseca, L., Mazier, D. and Renia, L., Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 2000. 30: 1646-1655.
12. Belnoue, E., Potter, S. M., Rosa, D. S., Mauduit, M., Gruner, A. C., Kayibanda, M., Mitchell, A. J. et al., Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008. 30: 544-553.
13. Amante, F. H., Haque, A., Stanley, A. C., Rivera Fde, L., Randall, L. M., Wilson, Y. A., Yeo, G. et al., Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 2010. 185: 3632-3642.
14. Villegas-Mendez, A., Greig, R., Shaw, T. N., de Souza, J. B., Gwyer Findlay, E., Stumhofer, J. S., Hafalla, J. C. et al., IFN-gamma-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J. Immunol. 2012. 189: 968-979.
15. Desvignes, L., Wolf, A. J. and Ernst, J. D., Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 2012. 188: 6205-6215.
16. Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K. and Lenz, L. L., Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 2010. 207: 327-337.
17. Prinz, M. and Knobeloch, K. P., Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system. Front Immunol. 2012. 3: 67.
18. Gonzalez-Navajas, J. M., Lee, J., David, M. and Raz, E., Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 2012. 12: 125-135.
19. Vigario, A. M., Belnoue, E., Gruner, A. C., Mauduit, M., Kayibanda, M., Deschemin, J. C., Marussig, M. et al., Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 2007. 178: 6416-6425.
20. Morrell, C. N., Srivastava, K., Swaim, A., Lee, M. T., Chen, J., Nagineni, C., Hooks, J. J. et al., Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun. 2011. 79: 1750-1758.
21. Haque, A., Best, S. E., Ammerdorffer, A., Desbarrieres, L., de Oca, M. M., Amante, F. H., de Labastida Rivera, F. et al., Type I interferons suppress CD4(+) T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 2011. 41: 2688-2698.
22. Bagot, S., Nogueira, F., Collette, A., do Rosario, V., Lemonier, F., Cazenave, P. A. and Pied, S., Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria. Infect. Immun. 2004. 72: 2817-2826.
23. Franke-Fayard, B., Trueman, H., Ramesar, J., Mendoza, J., van der Keur, M., van der Linden, R., Sinden, R. E. et al., A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 2004. 137: 23-33.
24. Grau, G. E., Piguet, P. F., Gretener, D., Vesin, C. and Lambert, P. H., Immunopathology of thrombocytopenia in experimental malaria. Immunology 1988. 65: 501-506.
25. Cox, D. and McConkey, S., The role of platelets in the pathogenesis of cerebral malaria. Cell Mol. Life Sci. 2010. 67: 557-568.
26. Kampfl, A. W., Birbamer, G. G., Pfausler, B. E., Haring, H. P. and Schmutzhard, E., Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings. Am. J. Trop. Med. Hyg. 1993. 48: 818-822.
27. Looareesuwan, S., Wilairatana, P., Krishna, S., Kendall, B., Vannaphan, S., Viravan, C. and White, N. J., Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin. Infect. Dis. 1995. 21: 300-309.
28. Cordoliani, Y. S., Sarrazin, J. L., Felten, D., Caumes, E., Leveque, C. and Fisch, A., MR of cerebral malaria. AJNR Am. J. Neuroradiol. 1998. 19: 871-874.
29. Patankar, T. F., Karnad, D. R., Shetty, P. G., Desai, A. P. and Prasad, S. R., Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology 2002. 224: 811-816.
30. Penet, M. F., Viola, A., Confort-Gouny, S., Le Fur, Y., Duhamel, G., Kober, F., Ibarrola, D. et al., Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J. Neurosci. 2005. 25: 7352-7358.
31. Stoelcker, B., Hehlgans, T., Weigl, K., Bluethmann, H., Grau, G. E. and Mannel, D. N., Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect. Immun. 2002. 70: 5857-5859.
32. Engwerda, C. R., Mynott, T. L., Sawhney, S., De Souza, J. B., Bickle, Q. D. and Kaye, P. M., Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 2002. 195: 1371-1377.
33. Togbe, D., de Sousa, P. L., Fauconnier, M., Boissay, V., Fick, L., Scheu, S., Pfeffer, K. et al., Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One 2008. 3: e2608.
34. Mohan, A., Sharma, S. K. and Bollineni, S., Acute lung injury and acute respiratory distress syndrome in malaria. J. Vector Borne Dis. 2008. 45: 179-193.
35. Taylor, W. R., Hanson, J., Turner, G. D., White, N. J. and Dondorp, A. M., Respiratory manifestations of malaria. Chest 2012. 142: 492-505.
36. Chang, W. L., Jones, S. P., Lefer, D. J., Welbourne, T., Sun, G., Yin, L., Suzuki, H. et al., CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 2001. 69: 7341-7348.
37. Epiphanio, S., Campos, M. G., Pamplona, A., Carapau, D., Pena, A. C., Ataide, R., Monteiro, C. A. et al., VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog. 2010. 6: e1000916.
38. Haque, A., Best, S. E., Unosson, K., Amante, F. H., de Labastida, F., Anstey, N. M., Karupiah, G. et al., Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 2011. 186: 6148-6156.
39. Campanella, G. S., Tager, A. M., El Khoury, J. K., Thomas, S. Y., Abrazinski, T. A., Manice, L. A., Colvin, R. A. et al., Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 2008. 105: 4814-4819.
40. Nie, C. Q., Bernard, N. J., Norman, M. U., Amante, F. H., Lundie, R. J., Crabb, B. S., Heath, W. R. et al., IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009. 5: e1000369.
41. Fauconnier, M., Palomo, J., Bourigault, M. L., Meme, S., Szeremeta, F., Beloeil, J. C., Danneels, A. et al., IL-12Rbeta2 is essential for the development of experimental cerebral malaria. J. Immunol. 2012. 188: 1905-1914.
42. Sharma, S., DeOliveira, R. B., Kalantari, P., Parroche, P., Goutagny, N., Jiang, Z., Chan, J. et al., Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 2011. 35: 194-207.
43. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
44. Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G. et al., A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 1995. 92: 11284-11288.
45. Van den Steen, P. E., Deroost, K., Van Aelst, I., Geurts, N., Martens, E., Struyf, S., Nie, C. Q. et al., CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur. J. Immunol. 2008. 38: 1082-1095.
46. Griffith, J. W., O'Connor, C., Bernard, K., Town, T., Goldstein, D. R. and Bucala, R., Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J. Infect. Dis. 2007. 196: 1553-1564.
47. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K. P., Hanisch, U. K., Raasch, J., Merkler, D. et al., Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008. 28: 675-686.
48. Hamby, M. E., Coppola, G., Ao, Y., Geschwind, D. H., Khakh, B. S. and Sofroniew, M. V., Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple g-protein-coupled receptors. J. Neurosci. 2012. 32: 14489-14510.
49. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J. et al., Immune response in mice that lack the interferon-gamma receptor. Science 1993. 259: 1742-1745.
50. Schofield, L. and Hackett, F., Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 1993. 177: 145-153.
51. Coban, C., Igari, Y., Yagi, M., Reimer, T., Koyama, S., Aoshi, T., Ohata, K. et al., Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 2010. 7: 50-61.